Benzinga's Top Pre-Market Gainers

by Lisa Levin, Benzinga Editor

September 13, 2012 8:12 AM | 1 min read | Make a Comment

K12

LRN

soared 13.66% to $24.30 in the pre-market trading. K12 reported a better-than-expected fourth-quarter profit. Vical

VICL

surged 9.28% to $4.12 in the pre-market session. Vical announced today a worldwide, nonexclusive license to Bristol-Myers Squibb Company

BMY

. Cliffs Natural Resources

CLF

added 2.41% to $41.60 in the pre-market session. Cliffs Natural Resources' PEG ratio is 1.09. Arena Pharmaceuticals

ARNA

moved up 1.79% to $8.51 in the pre-market session. Arena Pharmaceuticals shares have surged 464.87% over the past 52 weeks, while the S&P 500 index has gained 20.85% in the same period.

Market News and Data brought to you by Benzinga APIs

Posted In: News Pre-Market Outlook Markets Movers Consumer Discretionary Education Services Top Pre-Market Gainers

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!